Page 1 | Search Results | Blood | American Society of Hematology

Skip to Main Content

Skip Nav Destination

1-4 of 4

Sort by

Sort Order Select

Journal Articles

Safety and Efficacy of CD30-Directed Chimeric Antigen Receptor T Cell Therapy Plus Camrelizumab in Patients with Relapsed/Refractory CD30+ Lymphoma

Min Yu, Fancong Kong, Yulan Zhou, Tongcun Zhang, Fei Li, Ling Qi

Blood (2024) 144 (Supplement 1): 3465.

https://doi.org/10.1182/blood-2024-193279

Published: 2024

Journal Articles

MYD88 Mutations in Chronic Lymphocytic Leukemia Exhibit Distinct Biological Behaviors and Prognostic Implications

Yuting Yan, Yulan Zhou, Weihao Chen, Jun Wang, Tingyu Wang, Ying Yu, Yujiao Jia, Zhen Yu, Lugui Qiu, Fei Li, Shuhua Yi

Blood (2024) 144 (Supplement 1): 4624.

https://doi.org/10.1182/blood-2024-207323

Published: 2024

Journal Articles

Efficacy and Safety of CD19-Specific CAR-T Cell Therapy Following Immunochemotherapy in Newly Diagnosed B-Cell Lymphoma Associated Hemophagocytic Lymphohistiocytosis

Yulan Zhou, Yulong Jin, Dexiang Ji, Fancong Kong, Yu Peng, Min Yu, Shixuan Wang, Xiaoye Cheng, Fei Li

Blood (2023) 142 (Supplement 1): 4843.

https://doi.org/10.1182/blood-2023-189192

Published: 2023

Journal Articles

Orelabrutinib, Fludarabine, Cyclophosphamide, and Obinutuzumab (OFCG) for First-Line Treatment of Chronic Lymphocytic Leukemia: A Multicenter, Investigator-Initiated Study (cwCLL-001 study)

Huayuan Zhu, Li Wang, Lei Fan, Fei Li, Yulan Zhou, Wei Xu, Jianyong Li

Blood (2022) 140 (Supplement 1): 12421–12422.

https://doi.org/10.1182/blood-2022-169381

Published: 2022